跳至主要内容
临床试验/NL-OMON38623
NL-OMON38623撤回不适用

Evaluation of tumor response during and after (chemo)radiotherapy for patients with oropharyngeal squamous cell carcinoma using functional imaging by diffusion-weighted MRI - PREDICT

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with histological proven squamous cell carcinoma of the orpharynx scheduled for (chemo)radiotherapy.

排除标准

  • -Patients with recurrence of previously confirmed head and neck squamous cell carcinoma.
  • -Patients undergoing any other treatment option for the primary tumor like surgery.
  • -Patients with other types of head and neck malignancies: lymphatic neoplasms, esophageal malignancies, thyroid cancer, lip cancer, skin cancers and other malignancies not originating from the pharynx.
  • -Having any physical or mental status that interferes with the informed consent procedure.
  • -Contraindications for MRI (e.g. claustrophobia, arterial clips in central nervous system)

研究者

相似试验